|
End-of-day quote
Shenzhen S.E.
2026-10-22
|
5-day change | 1st Jan Change | ||
| 5.110 CNY | -3.22% |
|
-4.13% | -30.66% |
| 08-25 | Beijing SL Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 06-01 | Beijing SL Pharmaceutical Co., Ltd. Approves Cash Dividend for 2025 | CI |
| Market Cap | 5.41B 811M 724M 668M 607M 1.14B 76.82B 1.16B 8.05B 3.17B 40.25B 3.04B 2.98B 127B | P/E 2024 |
-107x | P/E 2025 | -21.7x |
|---|---|---|---|---|---|
| Enterprise Value | 4.27B 640M 571M 527M 479M 898M 60.63B 912M 6.35B 2.5B 31.76B 2.4B 2.35B 101B | EV / Sales 2024 |
8.62x | EV / Sales 2025 | 10.3x |
| Free-Float |
59.02% | Yield 2024 |
0.27% | Yield 2025 | 0.14% |
| 1 day | -3.22% | ||
| 1 week | -4.13% | ||
| Current month | -11.13% | ||
| 1 month | -13.54% | ||
| 3 months | -7.93% | ||
| 6 months | -30.57% | ||
| Current year | -30.66% |
| 1 week | 5.1 |  | 5.34 |
| 1 month | 5.1 | | 5.85 |
| Current year | 4.81 | | 9.4 |
| 1 year | 4.81 | | 9.4 |
| 3 years | 4.81 | | 12.99 |
| 5 years | 4.81 | | 16.09 |
| 10 years | 4.81 | | 33.03 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ming Bo Xu
CEO | Chief Executive Officer | 62 | 2006-04-10 |
Shu Jie Liang
SEC | Corporate Secretary | 60 | 2006-04-10 |
| Director | Title | Age | Since |
|---|---|---|---|
Ming Bo Xu
CHM | Chairman | 62 | 2006-04-10 |
Shu Jie Liang
BRD | Director/Board Member | 60 | 2009-04-23 |
Yan Ming Qi
CHM | Chairman | 56 | 2015-05-27 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 11/5/25 | Buy | Director | 100 | 0.0000% | ||
| 10/29/25 | Sell | Director | 35,100 | 0.0041% | ||
| 10/28/25 | Sell | Director | 340,000 | 0.0399% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.22% | -4.13% | -34.40% | -59.92% | 786M | |
| -2.01% | +1.69% | +55.70% | +121.68% | 1,165B | |
| -1.38% | +3.15% | +36.96% | +74.13% | 645B | |
| -0.44% | -0.79% | +24.06% | +95.65% | 504B | |
| -0.40% | +3.06% | +43.89% | +64.51% | 380B | |
| -2.14% | -1.48% | +64.93% | +39.12% | 363B | |
| -0.76% | +2.42% | +22.20% | +51.15% | 297B | |
| -1.81% | +1.98% | +1.57% | +25.66% | 269B | |
| -1.05% | +1.92% | +50.50% | +61.43% | 237B | |
| -0.25% | -0.13% | +29.19% | +101.12% | 195B | |
| Average | -1.44% | +1.95% | +29.46% | +57.45% | 405.63B | |
| Weighted average by Cap. | -1.38% | +3.17% | +40.86% | +82.05% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 660M 98.92M 88.3M 81.46M 74.01M 139M 9.37B 141M 981M 387M 4.91B 371M 363M 15.55B | 624M 93.42M 83.38M 76.93M 69.89M 131M 8.85B 133M 927M 365M 4.64B 351M 343M 14.69B |
| Net income | -74.07M -11.09M -9.9M -9.14M -8.3M -15.57M -1.05B -15.81M -110M -43.35M -551M -41.64M -40.75M -1.74B | -347M -52.01M -46.42M -42.83M -38.91M -72.99M -4.93B -74.11M -516M -203M -2.58B -195M -191M -8.18B |
| Net Debt | -1.98B -297M -265M -245M -222M -417M -28.13B -423M -2.95B -1.16B -14.74B -1.11B -1.09B -46.68B | -1.14B -171M -153M -141M -128M -240M -16.19B -244M -1.7B -668M -8.48B -642M -628M -26.88B |
Employees
901
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-23 | CN¥5.270 | +3.13% | 21,903,310 |
| 26-10-22 | CN¥5.110 | -3.22% | 15,406,696 |
| 26-10-21 | CN¥5.280 | +0.57% | 13,351,702 |
| 26-10-20 | CN¥5.250 | +0.77% | 11,592,202 |
| 26-10-19 | CN¥5.210 | -1.51% | 15,470,300 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 002038 Stock
Select your edition
All financial news and data tailored to specific country editions
